Brief: Milestone Pharmaceuticals Announces $125 Million Strategic Financing With RTW Investments To Support The Advancement Of Etripamil For PSVT
28/03/2023 15:33
March 28 (Reuters) - Milestone Pharmaceuticals Inc
MIST.O :
* MILESTONE PHARMACEUTICALS ANNOUNCES $125 MILLION STRATEGIC
FINANCING WITH RTW INVESTMENTS TO SUPPORT THE ADVANCEMENT OF
ETRIPAMIL FOR PSVT
* MILESTONE PHARMACEUTICALS INC - PROCEEDS FROM STRATEGIC
FINANCING TOGETHER WITH YEAR-END CASH RESOURCES EXPECTED TO FUND
OPERATIONS INTO MID-2025
Source text for Eikon: ID:nCNWNKvlRa
Further company coverage: MIST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Milestone Pharmaceuticals
See all newsBrief: Milestone Pharmaceuticals Announces First European Study Participant Enrolled In Revera-301 Phase 3 Clinical Trial
Brief: Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment To The Co
Milestone Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Canada's Milestone Pharma misses Q2 product revenue expectations
Milestone Pharmaceuticals Inc expected to post a loss of 19 cents a share - Earnings Preview